Abstract
Generics (UK) Ltd (t/a Mylan) v Yeda Research and Development Company Ltd [2017] EWHC 2629 (Pat), High Court of England and Wales, 26 October 2017 In light of the recent Supreme Court decision in Actavis UK Ltd v Eli Lilly and Co [2017] UKSC 48, the Patents Court has considered the correct approach to the interpretation of patent claims and Mr Justice Arnold has held that the doctrine of equivalents does not apply when assessing novelty.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Intellectual Property Law & Practice
Paper Title
Journal
Date
